Cemiplimab for Secondary Angiosarcomas

Clinical trial NCT04873375 · COMPLETED

Trial details

NCT number: NCT04873375
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Secondary Angiosarcoma Locally Advanced Sarcoma Metastasis

Start date: 2022-01-01
Primary completion: 2024-10-09
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.